Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Fitzgerald

Showing results (1-10 of 46) with videos related to

Pageof 5
Sort By:
Postgraduate Medical Journal|January 1, 1977
Why another beta-antagonist?J D Fitzgerald
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982
The effect of different classes of beta-antagonists on clinical and experimental hypertensionJ D Fitzgerald
Acta Cardiologica|January 1, 1972
The pharmacology of practolol, a cardioselective beta adrenergic blocking drugJ D Fitzgerald
International Journal of Clinical Pharmacology and Biopharmacy|April 1, 1975
Beta blocking drugs as anti-arrhythmic agentsJ D Fitzgerald
Postgraduate Medical Journal|January 1, 1976
Beta-blockade and mechanisms of diseaseJ D Fitzgerald
British Medical Journal|December 19, 1970
Beta-blockers in hypertensionJ D Fitzgerald
Acta Cardiologica|January 1, 1972
Beta adrenergic blocking drugs. Present position and future developmentJ D Fitzgerald
Journal of Cardiovascular Pharmacology|January 1, 1988
Age-related effects of beta-blockers and hypertensionJ D Fitzgerald
Acta Medica Scandinavica. Supplementum|January 1, 1985
The possible role of the ancillary properties of beta adrenoceptor antagonists in the management of angina pectorisJ D Fitzgerald
Cardiovascular Drugs and Therapy|June 1, 1991
Introduction to focused section on new developments in beta blockadeJ D Fitzgerald
Pageof 5

Showing results (1-10 of 46) with videos related to

Sort By:
Pageof 5
Postgraduate Medical Journal|January 1, 1977
Why another beta-antagonist?J D Fitzgerald
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1982
The effect of different classes of beta-antagonists on clinical and experimental hypertensionJ D Fitzgerald
Acta Cardiologica|January 1, 1972
The pharmacology of practolol, a cardioselective beta adrenergic blocking drugJ D Fitzgerald
International Journal of Clinical Pharmacology and Biopharmacy|April 1, 1975
Beta blocking drugs as anti-arrhythmic agentsJ D Fitzgerald
Postgraduate Medical Journal|January 1, 1976
Beta-blockade and mechanisms of diseaseJ D Fitzgerald
British Medical Journal|December 19, 1970
Beta-blockers in hypertensionJ D Fitzgerald
Acta Cardiologica|January 1, 1972
Beta adrenergic blocking drugs. Present position and future developmentJ D Fitzgerald
Journal of Cardiovascular Pharmacology|January 1, 1988
Age-related effects of beta-blockers and hypertensionJ D Fitzgerald
Acta Medica Scandinavica. Supplementum|January 1, 1985
The possible role of the ancillary properties of beta adrenoceptor antagonists in the management of angina pectorisJ D Fitzgerald
Cardiovascular Drugs and Therapy|June 1, 1991
Introduction to focused section on new developments in beta blockadeJ D Fitzgerald
Pageof 5